Your browser doesn't support javascript.
loading
Heightened BTK-dependent cell proliferation in unmutated chronic lymphocytic leukemia confers increased sensitivity to ibrutinib.
Guo, Ailin; Lu, Pin; Galanina, Natalie; Nabhan, Chadi; Smith, Sonali M; Coleman, Morton; Wang, Y Lynn.
Afiliação
  • Guo A; Division of Genomic and Molecular Pathology, Department of Pathology, University of Chicago, Chicago, IL, USA.
  • Lu P; Division of Genomic and Molecular Pathology, Department of Pathology, University of Chicago, Chicago, IL, USA.
  • Galanina N; Department of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, IL, USA.
  • Nabhan C; Department of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, IL, USA.
  • Smith SM; Department of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, IL, USA.
  • Coleman M; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Wang YL; Division of Genomic and Molecular Pathology, Department of Pathology, University of Chicago, Chicago, IL, USA.
Oncotarget ; 7(4): 4598-610, 2016 Jan 26.
Article em En | MEDLINE | ID: mdl-26717038

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Proteínas Tirosina Quinases / Leucemia Linfocítica Crônica de Células B / Biomarcadores Tumorais / Resistencia a Medicamentos Antineoplásicos / Proliferação de Células / Mutação Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Proteínas Tirosina Quinases / Leucemia Linfocítica Crônica de Células B / Biomarcadores Tumorais / Resistencia a Medicamentos Antineoplásicos / Proliferação de Células / Mutação Idioma: En Ano de publicação: 2016 Tipo de documento: Article